FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Volker Gross

Research Profile

Disorders

Anatomy

Living Beings

Rats

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Oliver Stoeltzing; Martin Loss; Elisabeth Huber; Volker Gross; Christoph Eilles; Jan Mueller-Brand; Hans J Schlitt
Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor.
F Rieder; Okka W Hamer; Cornelia M Gelbmann; Jurgen Schölmerich; Volker Gross; Stefan Feuerbach; Hans Herfarth; Gerhard Rogler
Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx".
Nicole Bregenzer; A Lange; Alois Fürst; Volker Gross; Jurgen Schölmerich; Tilo Andus
Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Volker Gross (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Oliver Stoeltzing; Martin Loss; Elisabeth Huber; Volker Gross; Christoph Eilles; Jan Mueller-Brand; Hans J Schlitt
Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2010;395(2):185-92.
2006: F Rieder; Okka W Hamer; Cornelia M Gelbmann; Jurgen Schölmerich; Volker Gross; Stefan Feuerbach; Hans Herfarth; Gerhard Rogler
Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx".
Zeitschrift für Gastroenterologie 2006;44(7):599-602.
2005: Nicole Bregenzer; A Lange; Alois Fürst; Volker Gross; Jurgen Schölmerich; Tilo Andus
Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being.
Zeitschrift für Gastroenterologie 2005;43(4):367-71.
2004: Hans Herfarth; Volker Gross; Tilo Andus; I Caesar; Harald Vogelsang; Guido Adler; Helmut Malchow; A Petri; Michael Gierend; Jurgen Schölmerich
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization.
International journal of colorectal disease 2004;19(2):147-52.
2003: Tilo Andus; Volker Gross; I Caesar; H J Schulz; Herbert Lochs; W D Strohm; Michael Gierend; A Weber; K Ewe; Jurgen Schölmerich
Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.
Digestive diseases and sciences 2003;48(2):373-8.
2002: Cornelia M Gelbmann; Gerhard Rogler; Volker Gross; Michael Gierend; Nicole Bregenzer; Tilo Andus; Jürgen Schölmerich
Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
The American journal of gastroenterology 2002;97(6):1438-45.
2001: Cornelia M Gelbmann; Gerhard Rogler; Michael Gierend; Volker Gross; Jurgen Schölmerich; Tilo Andus
Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease.
European journal of gastroenterology & hepatology 2001;13(12):1431-7.
2001: Frank Kullmann; Helmut Messmann; M Alt; Volker Gross; T Bocker; Jurgen Schölmerich; Josef Rüschoff
Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats.
International journal of colorectal disease 2001;16(4):238-46.
2000: Wolfgang Hans; Jurgen Schölmerich; Volker Gross; Werner Falk
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice.
European journal of gastroenterology & hepatology 2000;12(3):267-73.
2000: Wolfgang Hans; Jurgen Schölmerich; Volker Gross; Werner Falk
Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice.
European cytokine network 2000;11(1):67-74.
2000: R Daig; Gerhard Rogler; Elisabeth Aschenbrenner; Daniela Vogl; Werner Falk; Volker Gross; Jurgen Schölmerich; Tilo Andus
Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.
Gut 2000;46(3):350-8.
2000: Gerhard Rogler; Elisabeth Aschenbrenner; Volker Gross; E F Stange; Jurgen Schölmerich
Intracellular transport of high-density lipoprotein 3 in intestinal epithelial cells (Caco-2) is tubulin associated.
Digestion 2000;61(1):47-58.
1999: Gerhard Rogler; Martin Hausmann; Tanja Spöttl; Daniela Vogl; Elisabeth Aschenbrenner; Tilo Andus; Werner Falk; Jurgen Schölmerich; Volker Gross
T-cell co-stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa.
European journal of gastroenterology & hepatology 1999;11(10):1105-11.
1999: Cornelia M Gelbmann; S Mestermann; Volker Gross; M Köllinger; Jurgen Schölmerich; Werner Falk
Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin.
Gut 1999;45(2):210-7.
1999: Florian Obermeier; G Kojouharoff; Wolfgang Hans; Jurgen Schölmerich; Volker Gross; Werner Falk
Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.
Clinical and experimental immunology 1999;116(2):238-45.
1998: Rainer H Straub; Daniela Vogl; Volker Gross; B Lang; Jurgen Schölmerich; Tilo Andus
Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
The American journal of gastroenterology 1998;93(11):2197-202.
1998: Helmut Messmann; Peter Schaller; Tilo Andus; Guntram Lock; W Vogt; Volker Gross; Hubert Zirngibl; K H Wiedmann; T Lingenfelser; K Bauch; HG Leser; Jurgen Schölmerich; Axel Holstege
Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.
Endoscopy 1998;30(7):583-9.
1998: Gerhard Rogler; K Brand; Daniela Vogl; S Page; Robert Hofmeister; Tilo Andus; R Knuechel; P A Baeuerle; Jurgen Schölmerich; Volker Gross
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.
Gastroenterology 1998;115(2):357-69.
1998: Gerhard Rogler; R Daig; Elisabeth Aschenbrenner; Daniela Vogl; Klaus Schlottmann; Werner Falk; Volker Gross; Jurgen Schölmerich; Tilo Andus
Establishment of long-term primary cultures of human small and large intestinal epithelial cells.
Laboratory investigation; a journal of technical methods and pathology 1998;78(7):889-90.
1998: Helmut Messmann; Frank Kullmann; T Wild; Ruth Knüchel-Clarke; Josef Rüschoff; Volker Gross; Jurgen Schölmerich; Axel Holstege
Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid.
Endoscopy 1998;30(4):333-8.
1998: Gerhard Rogler; Martin Hausmann; Daniela Vogl; Elisabeth Aschenbrenner; Tilo Andus; Werner Falk; Reinhard Andreesen; Jurgen Schölmerich; Volker Gross
Isolation and phenotypic characterization of colonic macrophages.
Clinical and experimental immunology 1998;112(2):205-15.
1998: Volker Gross; Tilo Andus; Karl-Walter Ecker; Andreas Raedler; K Loeschke; M Plauth; J Rasenack; A Weber; Michael Gierend; K Ewe; Jurgen Schölmerich
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group.
Gut 1998;42(4):493-6.
1997: Frank Kullmann; H Arndt; Volker Gross; J Rüschoff; Jurgen Schölmerich
Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
European journal of gastroenterology & hepatology 1997;9(12):1205-11.
1997: Rainer H Straub; E Antoniou; M Zeuner; Volker Gross; Jurgen Schölmerich; Tilo Andus
Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn's disease and ulcerative colitis.
Journal of neuroimmunology 1997;80(1-2):149-57.
1997: Rainer H Straub; Tilo Andus; Guntram Lock; M Zeuner; Klaus-Dieter Palitzsch; Volker Gross; B Lang; Jurgen Schölmerich
[Cardiovascular and pupillary autonomic and somatosensory neuropathy in chronic diseases with autoimmune phenomena. A comparative study of patients with Crohn disease, ulcerative colitis, systemic lupus erythematosus, progressive systemic sclerosis and type I diabetes mellitus].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(11):647-53.
1997: Tilo Andus; R Daig; Daniela Vogl; Elisabeth Aschenbrenner; Guntram Lock; Stephan Hollerbach; M Köllinger; Jurgen Schölmerich; Volker Gross
Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Gut 1997;41(5):651-7.
1997: Gerhard Rogler; Tilo Andus; Elisabeth Aschenbrenner; Daniela Vogl; Werner Falk; Jurgen Schölmerich; Volker Gross
Alterations of the phenotype of colonic macrophages in inflammatory bowel disease.
European journal of gastroenterology & hepatology 1997;9(9):893-9.
1997: I Caesar; Volker Gross; M Roth; Tilo Andus; W Hohenberger; Jurgen Schölmerich
[Steroid-induced myopathy in left-sided ulcerative colitis. Successful treatment and continued therapy with the topical steroid budesonide].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(6):358-62.
1997: I Caesar; Volker Gross; M Roth; Tilo Andus; C Schmidt; R Raedsch; A Weber; Michael Gierend; K Ewe; Jurgen Schölmerich
Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.
Hepato-gastroenterology 1997;44(14):445-51.
1997: Frank Kullmann; Volker Gross; J Rüschoff; H Arndt; W Benda; A Winkler von Mohrenfels; Jurgen Schölmerich
Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats.
Zeitschrift für Gastroenterologie 1997;35(3):171-8.
1997: G Kojouharoff; Wolfgang Hans; Florian Obermeier; Daniela N Männel; Tilo Andus; Jurgen Schölmerich; Volker Gross; Werner Falk
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice.
Clinical and experimental immunology 1997;107(2):353-8.
1996: Gerhard Rogler; Stephan Hollerbach; T Bocker; VD Mohr; B Denner; G Lehner; Hubert Zirngibl; Volker Gross; Axel Holstege; Jurgen Schölmerich
[Endosonographic demonstration of extrapancreatic and extraintestinal gastrinoma].
Deutsche medizinische Wochenschrift (1946) 1996;121(49):1531-6.
1996: Volker Gross; Tilo Andus; I Caesar; S C Bischoff; H Lochs; A Tromm; H J Schulz; U Bär; A Weber; Michael Gierend; K Ewe; Jurgen Schölmerich
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
European journal of gastroenterology & hepatology 1996;8(9):905-9.
1996: A Lange; E Haslbeck; Tilo Andus; Nicole Bregenzer; Volker Gross; Jurgen Schölmerich; R Lamparter-Lang
[Ambulatory education of patient with Crohn disease/ulcerative colitis].
Zeitschrift für Gastroenterologie 1996;34(7):411-5.
1996: Nicole Bregenzer; A Lange; Volker Gross; Tilo Andus; Jurgen Schölmerich; R Lamparter-Lang
[Quality of life in chronic inflammatory bowel diseases].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(6):396-401.
1996: Ulf Müller-Ladner; Volker Gross; Tilo Andus; H Gschwendtner; M Roth; I Caesar; Jurgen Schölmerich; B Lang
Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
European journal of gastroenterology & hepatology 1996;8(6):579-84.
1996: Frank Kullmann; M Fadaie; Volker Gross; Ruth Knüchel; T Bocker; P Steinbach; Jurgen Schölmerich; J Rüschoff
Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease.
European journal of gastroenterology & hepatology 1996;8(4):371-9.
1996: R Daig; Tilo Andus; Elisabeth Aschenbrenner; Werner Falk; Jurgen Schölmerich; Volker Gross
Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Gut 1996;38(2):216-22.
1996: Ulf Müller-Ladner; Tilo Andus; B Lang; Volker Gross
[Importance of ANCAs in the pathogenesis of chronic inflammatory bowel diseases].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1996;80():215.
1995: Volker Gross; Tilo Andus; W Fischbach; A Weber; Michael Gierend; F Hartmann; Jurgen Schölmerich
Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.
Zeitschrift für Gastroenterologie 1995;33(10):581-4.
1995: Volker Gross; Tilo Andus; Jurgen Schölmerich
[Crohn disease: prevention and drug therapy].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 1995;66(8):757-63.
1995: I Caesar; Volker Gross; M Roth; Tilo Andus; C Schmidt; R Raedsch; A Weber; Michael Gierend; K Ewe; Jurgen Schölmerich
Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group.
Zeitschrift für Gastroenterologie 1995;33(5):247-50.
1995: A Geissler; Tilo Andus; M Roth; Frank Kullmann; I Caesar; Paul Held; Volker Gross; Stefan Feuerbach; Jurgen Schölmerich
Focal white-matter lesions in brain of patients with inflammatory bowel disease.
Lancet 1995;345(8954):897-8.
1995: Volker Gross; Tilo Andus; R Daig; Elisabeth Aschenbrenner; Jurgen Schölmerich; Werner Falk
Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29).
Gastroenterology 1995;108(3):653-61.
1995: Helmut Messmann; Stephan Hollerbach; Volker Gross; Axel Holstege; R Büttner; J Schmidt; W Hohenberger; Jurgen Schölmerich
[Multiple gastric wall abscesses--a rare differential endosonographic diagnosis of submucous stomach tumors].
Zeitschrift für Gastroenterologie 1995;33(3):170-2.
1995: E Frick; Stephan Hollerbach; Volker Gross; Jurgen Schölmerich
[Diagnosis of round liver lesions].
Leber, Magen, Darm 1995;25(1):12-7.
1994: Stephan Hollerbach; E Frick; Frank Kullmann; Guntram Lock; Volker Gross; Jurgen Schölmerich
Clinical significance of sonographic findings in outpatient clinics.
Bildgebung = Imaging 1994;61(4):242-7.
1994: Volker Gross; H Arndt; Tilo Andus; Klaus-Dieter Palitzsch; Jurgen Schölmerich
Free radicals in inflammatory bowel diseases pathophysiology and therapeutic implications.
Hepato-gastroenterology 1994;41(4):320-7.
1993: Volker Gross; HG Leser; A Heinisch; Jurgen Schölmerich
Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis?
Hepato-gastroenterology 1993;40(6):522-30.
1993: Tilo Andus; Volker Gross; I Caesar; D Krumm; J Hosp; W Gerok; Jurgen Schölmerich
PMN-elastase in assessment of patients with inflammatory bowel disease.
Digestive diseases and sciences 1993;38(9):1638-44.
1993: Tilo Andus; Klaus-Dieter Palitzsch; Volker Gross; Jurgen Schölmerich
[The metabolic and endocrine functions of the cytokines].
Deutsche medizinische Wochenschrift (1946) 1993;118(9):306-13.
1992: Volker Gross; W E Hull; U Berger; Tilo Andus; W Kreisel; W Gerok; Dietrich Keppler
Inhibition of protein N-glycosylation by 2-deoxy-2-fluoro-D-galactose.
The Biochemical journal 1992;285 ( Pt 3)():821-6.
1992: Jurgen Schölmerich; M Lausen; L Lay; R Salm; Klaus Dieter Rückauer; Volker Gross; M Roth; HG Leser; Eduard H Farthmann
Value of endoscopic retrograde cholangiopancreatography in determining the cause but not course of acute pancreatitis.
Endoscopy 1992;24(4):244-7.
1992: Volker Gross; Reinhard Andreesen; HG Leser; M Ceska; E Liehl; M Lausen; Eduard H Farthmann; Jurgen Schölmerich
Interleukin-8 and neutrophil activation in acute pancreatitis.
European journal of clinical investigation 1992;22(3):200-3.
1992: Volker Gross; Tilo Andus; I Caesar; M Roth; Jurgen Schölmerich
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.
Gastroenterology 1992;102(2):514-9.
1991: Volker Gross; Tilo Andus; HG Leser; M Roth; Jurgen Schölmerich
Inflammatory mediators in chronic inflammatory bowel diseases.
Klinische Wochenschrift 1991;69(21-23):981-7.
1991: HG Leser; Volker Gross; C Scheibenbogen; A Heinisch; R Salm; M Lausen; Klaus Dieter Rückauer; Reinhard Andreesen; Eduard H Farthmann; Jurgen Schölmerich
Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis.
Gastroenterology 1991;101(3):782-5.
1991: Jurgen Schölmerich; Carl Schümichen; M Lausen; Volker Gross; HG Leser; L Lay; Eduard H Farthmann; W Gerok
Scintigraphic assessment of leukocyte infiltration in acute pancreatitis using technetium-99m-hexamethyl propylene amine oxine as leukocyte label.
Digestive diseases and sciences 1991;36(1):65-70.
1990: Volker Gross; D Ludolph; D Vom Berg; W Kreisel; Tilo Andus; N Katz; S Giffhorn-Katz; Peter C Heinrich; W Gerok
Hepatocyte specific long lasting inhibition of protein N-glycosylation by D-galactosamine.
Biochimica et biophysica acta 1990;1036(2):143-50.
1990: JA Rump; Jurgen Schölmerich; Volker Gross; M Roth; R Helfesrieder; A Rautmann; J Lüdemann; Wolfgang L Gross; H H Peter
A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
Immunobiology 1990;181(4-5):406-13.
1990: Volker Gross; Jurgen Schölmerich; HG Leser; R Salm; M Lausen; Klaus Dieter Rückauer; Ulrich Schöffel; L Lay; A Heinisch; Eduard H Farthmann
Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin.
Digestive diseases and sciences 1990;35(1):97-105.
1989: D Ludolph; Volker Gross; N R Katz; S Giffhorn-Katz; W Kreisel; Peter C Heinrich; W Gerok
Effect of the alpha-glucosidase inhibitor N-hydroxyethyl-1-deoxynojirimycin (Bay m 1099) on the biosynthesis of liver secretory glycoproteins.
Biochemical pharmacology 1989;38(15):2479-86.
1989: Jurgen Schölmerich; Volker Gross; T Johannesson; G Brobmann; Klaus Dieter Rückauer; B Wimmer; W Gerok; Eduard H Farthmann
Detection of biliary origin of acute pancreatitis. Comparison of laboratory tests, ultrasound, computed tomography, and ERCP.
Digestive diseases and sciences 1989;34(6):830-3.
1989: Volker Gross; Tilo Andus; J Castell; D Vom Berg; Peter C Heinrich; W Gerok
O- and N-glycosylation lead to different molecular mass forms of human monocyte interleukin-6.
FEBS letters 1989;247(2):323-6.
1989: Volker Gross; K Steube; T A Tran-Thi; W Gerok; Peter C Heinrich
Role of N-glycosylation for the plasma clearance of rat liver secretory glycoproteins.
Biochemical Society transactions 1989;17(1):21-3.
1989: Volker Gross; Peter C Heinrich; D V Berg; K Steube; T A Tran-Thi; K Decker; W Gerok
Circulatory life time and organ distribution of differently glycosylated forms (unglycosylated, high-mannose type, hybrid type, complex type) of rat alpha-1-acid glycoprotein.
Progress in clinical and biological research 1989;300():231-4.
1988: J V Castell; T Geiger; Volker Gross; Tilo Andus; E Walter; T Hirano; T Kishimoto; Peter C Heinrich
Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat.
European journal of biochemistry / FEBS 1988;177(2):357-61.
1988: Volker Gross; Peter C Heinrich; D vom Berg; K Steube; Tilo Andus; T A Tran-Thi; K Decker; W Gerok
Involvement of various organs in the initial plasma clearance of differently glycosylated rat liver secretory proteins.
European journal of biochemistry / FEBS 1988;173(3):653-9.
1986: K Steube; Volker Gross; D Häussinger; T A Tran-Thi; K Decker; W Gerok; Peter C Heinrich
Clearance of acute-phase plasma proteins with no, high-mannose-, hybrid-, or complex type oligosaccharide side chains by the isolated perfused rat liver.
Biochemical and biophysical research communications 1986;141(3):949-55.
1985: Volker Gross; K Steube; T A Tran-Thi; W McDowell; R T Schwarz; K Decker; W Gerok; Peter C Heinrich
Secretion of high-mannose-type alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein by primary cultures of rat hepatocytes in the presence of the mannosidase I inhibitor 1-deoxymannojirimycin.
European journal of biochemistry / FEBS 1985;150(1):41-6.
1985: W Weber; K Steube; Volker Gross; T A Tran-Thi; K Decker; W Gerok; Peter C Heinrich
Unglycosylated rat alpha 1-proteinase inhibitor has a six-fold shorter plasma half-life than the mature glycoprotein.
Biochemical and biophysical research communications 1985;126(1):630-5.
1982: Volker Gross; T Geiger; T A Tran-Thi; F Gauthier; Peter C Heinrich
Biosynthesis and secretion of alpha 1-antitrypsin in primary cultures of rat hepatocytes. Characterization of differently glycosylated intracellular and extracellular forms.
European journal of biochemistry / FEBS 1982;129(2):317-23.